Cargando…
Multisystem Inflammatory Syndrome after Ad26.COV2.S vaccination
BACKGROUND: The multisystem inflammatory syndrome (MIS) is a rare and sometime life-threatening post-infectious complication of coronavirus disease 2019 (Covid-19) in children and adults. To date, only a very few reports have associated such systemic reaction with SARS-CoV-2 vaccination. CASE REPORT...
Autores principales: | Bova, Carlo, Vigna, Ernesto, Gentile, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779863/ https://www.ncbi.nlm.nih.gov/pubmed/35096528 http://dx.doi.org/10.1016/j.idcr.2022.e01411 |
Ejemplares similares
-
Ad26.COV2-S: Multisystem inflammatory syndrome: case report
Publicado: (2022) -
Ad26.COV2-S: Multisystem inflammatory syndrome in children and adolescents (MIS-C/A): case report
Publicado: (2021) -
Cerebral pheohyphomycosis due to curvularia species
por: Bova, Carlo, et al.
Publicado: (2022) -
Deep Venous Thrombosis after Ad26.COV2.S Vaccination in Adult Male
por: Hussain, Habiba, et al.
Publicado: (2021) -
Widespread annular eruption after Ad26.COV2.S COVID-19 vaccine
por: Song, Eingun James, et al.
Publicado: (2021)